celecoxib has been researched along with Fibrosis, Radiation in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib was given to mice twice daily for 40 consecutive days starting on the day of local thoracic irradiation (LTI) or 40 or 80 days later." | 1.39 | Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib. ( Hunter, NR; Liao, Z; Mason, KA; Milas, L; Thames, HD; Valdecanas, D, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter, NR | 1 |
| Valdecanas, D | 1 |
| Liao, Z | 1 |
| Milas, L | 1 |
| Thames, HD | 1 |
| Mason, KA | 1 |
1 other study available for celecoxib and Fibrosis, Radiation
| Article | Year |
|---|---|
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.
Topics: Animals; Celecoxib; Confidence Intervals; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, R | 2013 |